ArticleFrontiers in immunology2025

METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery.

Xie Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.